By Kang Jae-eun

SEOUL, Nov. 18 (Yonhap) -- Lotte Biologics Co. completed construction of its biomanufacturing facility in Incheon, just west of Seoul, on Wednesday, marking a major step in its efforts to become a leading player in the global biopharmaceutical market.

A completion ceremony for Plant 1, located at the company's Songdo Bio Campus in Incheon, was attended by the company's co-chief executive officers, James Park and Shin Yoo-yeol, as well as Lotte Group Chairman Shin Dong-bin.

"The bio business is Lotte Group's future growth engine and a next-generation industry that will lead Korea's next generation," Chairman Shin said at the event.

The production plant, spanning nearly 100,000 square meters, is equipped with key facilities, including a production building and a wastewater treatment facility. It has an annual production capacity of 120,000 liters and is scheduled to begin commercial operations by 2027, according to the company.

The facility is expected to provide the company with a large-scale production base in South Korea, complementing its manufacturing facility in Syracuse, New York, which it acquired in 2023, the company added.

"We plan to accelerate our business strategy linking our production hubs in South Korea and the United States to expand our presence in the global contract development and manufacturing development organizations (CDMO) market," the company said in a release.

Earlier this week, the Lotte Group subsidiary announced its first major contract manufacturing agreement with a global pharmaceutical company, without disclosing further details.

Lotte Biologics is widely seen as a key test of Shin Yoo-yeol's leadership, as the eldest son of the group's chairman and the conglomerate's third-generation heir apparent.

Shin was promoted to group president earlier this week and is expected to oversee the conglomerate's new growth engines, including its bio business.

A photo of the Plant 1 manufacturing facility at Lotte Biologics Co.'s Songdo Bio Campus in Incheon, just west of Seoul, provided by the company (PHOTO NOT FOR SALE) (Yonhap)

A photo of the Plant 1 manufacturing facility at Lotte Biologics Co.'s Songdo Bio Campus in Incheon, just west of Seoul, provided by the company (PHOTO NOT FOR SALE) (Yonhap)

fairydust@yna.co.kr
(END)

Keywords

Articles with issue keywords

Source: Yonhap News · Kang Jae-eun

At a glance

Topic
World
Country
🇰🇷 KR
Publisher language
EN
Added to Allnira